United States & Canada International
Home PageMagazineTravelPersonalsAbout
Advertise with us     Subscriptions     Contact us     Site map     Translate    

 
Table Of Contents
August 2002 Cover
August 2002 Cover

 HIV Digest HIV Digest Archive  
August 2002 Email this to a friend
Check out reader comments

Your dick on HIV drugs...

Protease inhibitor (PI)-based combination antiretroviral therapy has been associated with metabolic and endocrinologic adverse effects that were not apparent during pre-marketing clinical trials, such as hyperlipidemia, insulin resistance, and body fat redistribution. More recently, preliminary reports have suggested an increased incidence of sexual dysfunction among men treated with PIs. Researchers conducted a retrospective cohort study of 254 HIV-positive male PI recipients who received care from the staff-model division of a large New England HMO between 1993 and 1998 to investigate the potential association.

View our poll archive
Screening the full-text electronic medical record for mentions of erectile dysfunction and loss of libido using a text-string search identified cases of sexual dysfunction. Physician abstracters reviewed encounters identified by the search, and cases were considered confirmed if the patient described erectile dysfunction or loss of libido during the visit. CD4+ lymphocyte count, and serum HIV-1 RNA levels, serum total testosterone, free testosterone, luteinizing hormone, prolactin, and thyroid stimulating hormone (TSH or thyrotropin) were obtained from the HMO computerized laboratory database.

A total of 80 incident cases of sexual dysfunction were observed. The unadjusted rate of sexual dysfunction was elevated during any PI therapy. Relative to unexposed individuals, the rate of sexual dysfunction adjusted for confounding was most elevated with use of ritonavir, followed by indinavir, nelfinavir and saquinavir. The unadjusted association of sexual dysfunction with 3TC was significant, but slightly attenuated after adjusting for PI use and other possible confounding factors.

PI-based combination regimens for HIV came into widespread use in 1996. Because studies conducted before the PI era suggested that the incidence of sexual dysfunction increased with stage of HIV disease, a decline among patients treated with effective therapy was expected. However, preliminary reports have suggested the opposite.

Editor's Note: from the Journal of Acquired Immune Deficiency Syndromes


Guidemag.com Reader Comments
You are not logged in.

No comments yet, but click here to be the first to comment on this HIV Digest!

Custom Search

******


My Guide
Register Now!
Username:
Password:
Remember me!
Forget Your Password?




This Month's Travels
Travel Article Archive
Seen in Jacksonville
Heated indoor pool at Club Jacksonville

Seen in Fort Myers

Steve, Ray & Jason at Tubby's

Seen in Key West

Bartender Ryan of 801-Bourbon Bar, Key West



From our archives


Border police can spy on your laptop


Personalize your
Guidemag.com
experience!

If you haven't signed up for the free MyGuide service you are missing out on the following features:

- Monthly email when new
   issue comes out
- Customized "Get MyGuys"
   personals searching
- Comment posting on magazine
   articles, comment and
   reviews

Register now

 
Quick Links: Get your business listed | Contact us | Site map | Privacy policy







  Translate into   Translation courtesey of www.freetranslation.com

Question or comments about the site?
Please contact webmaster@guidemag.com
Copyright © 1998-2008 Fidelity Publishing, All rights reserved.